Consistent with previous studies, we found that serum GDF-15 expression is decreased in breast cancer-bearing mice, and diltiazem-induced GDF-15 exhibits anti-tumor effects by decreasing EMT and metastatic nodules of breast cancer. This evidence concerns the gene GDF15 and neoplasm.